Tafecta is the 1st global generic of TenofovirAlafenamide. TenofovirAlafenamide is an oral nucleoside reverse transcriptase inhibitor (NRTIs).Itis indicated for the treatment of chronic hepatitis b virus (HBV) infection in adults with compensated liver disease.
How does it work in HBV ?
The active substance in Tafecta,tenofoviralafenamide, works by stopping the hepatitis B virus in the
liver from multiplying. It is converted in the body into its active compound tenofovir, which blocks the
activity of reverse transcriptase, an enzyme made by the hepatitis B virus that allows it to reproduce
itself in the cells it has infected.